Avadel Pharmaceuticals PLC (NAS:AVDL)
$ 13.945 0.295 (2.16%) Market Cap: 1.34 Bil Enterprise Value: 1.24 Bil PE Ratio: 0 PB Ratio: 19.10 GF Score: 43/100

Avadel Pharmaceuticals PLC at SVB Leerink Global Healthcare Conference (Virtual) Transcript

Feb 24, 2021 / 08:40PM GMT
Release Date Price: $8.65 (-1.14%)
Ami Fadia
SVB Leerink LLC, Research Division - MD of Biopharma & Generics and Senior Analyst

Good afternoon, everyone. Welcome to the next session on Avadel. As a reminder, I'm Ami Fadia. I cover biopharma and generics at SVB Leerink. And if you've got any questions that you'd like me to ask management on your behalf, please free to send it over through the dashboard.

It's my pleasure to have the Avadel team here with me today. I'd like to kick it off by asking Greg Divis, who is the CEO of the company, to give us a little bit of an overview of the company for those who are not familiar, and then we can dive into questions.

Gregory J. Divis
Avadel Pharmaceuticals plc - CEO & Director

Thanks, Ami.

Ami Fadia
SVB Leerink LLC, Research Division - MD of Biopharma & Generics and Senior Analyst

Thank you.

Gregory J. Divis
Avadel Pharmaceuticals plc - CEO & Director

Yes, thanks. And most importantly, thank you for the opportunity to participate in

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot